Rosinka Kyiv Soft Drink Plant

4 records, newest first. Each line links to the FDA page it came from.

Refusal charges, in plain English

• COLOR LBLG3 refused lines

  Artificial coloring not declared

  The product appeared to contain an artificial coloring without labeling that states that fact.

• UNSAFE COL3 refused lines

  Color additive unsafe under section 721

  The product appeared to be, or to contain, a color additive that is unsafe within the meaning of section 721(a) of the FD&C Act, the section that governs which color additives may be used and how.

• LACKS N/C2 refused lines

  Net quantity statement missing

  The packaged food appeared not to carry an accurate statement of the quantity of contents, such as net weight, measure, or count, on its label.

• USUAL NAME1 refused line

  Common or usual name missing

  The label appeared not to show the common or usual name of the food.

Questions about Rosinka Kyiv Soft Drink Plant

Is Rosinka Kyiv Soft Drink Plant on an FDA import alert?

Yes. As of October 26, 2026, Rosinka Kyiv Soft Drink Plant is on the red list of FDA Import Alert 45-02, “Foods with illegal or undeclared colors”, for tarkun; feijoa; FDA published the listing on December 5, 2017.

Has FDA refused shipments from Rosinka Kyiv Soft Drink Plant?

Yes. FDA refused 3 shipment lines from Rosinka Kyiv Soft Drink Plant between February 2, 2018 and July 12, 2018. The most recent, on July 12, 2018, was carbonated soft drink, n.e.c., charged as UNSAFE COL (color additive unsafe under section 721).

Why did FDA refuse Rosinka Kyiv Soft Drink Plant's shipments?

The most frequent charges are COLOR LBLG (artificial coloring not declared, 3 lines) and UNSAFE COL (color additive unsafe under section 721, 3 lines).

What is Rosinka Kyiv Soft Drink Plant's FEI number?

Rosinka Kyiv Soft Drink Plant's FDA Establishment Identifier (FEI) is 3013848126.

Can shipments from Rosinka Kyiv Soft Drink Plant still enter the U.S.?

Shipments of tarkun; feijoa from Rosinka Kyiv Soft Drink Plant can be detained without physical examination under Import Alert 45-02; FDA releases them only if evidence shows they do not have the listed violation. Importers must consider this listing in their FSVP evaluation (21 CFR 1.505).